117 results match your criteria Laser Treatment of Benign Pigmented Lesions


Outcomes of 1064-nm picosecond laser alone and in combination with fractional 1064-nm picosecond laser in tattoo removal.

J Cosmet Dermatol 2022 Apr 29. Epub 2022 Apr 29.

Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Background: Removal of the unwanted tattoo was initially focused treatment of picosecond laser in the setting of the unfractionated beam, whereas the fractionated 1064-nm picosecond lasers (Fr-Pico) has been successfully utilized in various skin conditions, including scar and benign pigmented lesions. However, no studies compared the combination of Fr-Pico and unfractional 1064-nm picosecond laser (UFr-Pico) and UFr-Pico alone in tattoo removal.

Objective: This study aims to compare the efficacy and safety of the combination of Fr-Pico and UFr-Pico and the UFr-Pico and in tattoo removal. Read More

View Article and Full-Text PDF

[Syndroms associated with benign skin tumors].

Hautarzt 2022 Feb 25;73(2):114-126. Epub 2022 Jan 25.

Pädiatrische Dermatologie, Dermatoonkologisches Forschungungslabor, Colentina Klinik, Carol-Davila-Universität für Medizin und Pharmazie, Bukarest, Rumänien.

Benign skin tumors represent a wide category of diseases. The diagnosis is usually provided by the clinical aspect and the patient history. The pathological examination is not always considered necessary and in most cases the treatment is removal of the lesion by cryotherapy, electrosurgery or laser ablation. Read More

View Article and Full-Text PDF
February 2022

Preoperative AI-Driven Fluorescence Diagnosis of Non-Melanoma Skin Cancer.

Diagnostics (Basel) 2021 Dec 29;12(1). Epub 2021 Dec 29.

Department of Bioengineering, Imperial College London, South Kensington, London SW7 2BT, UK.

The diagnosis and treatment of non-melanoma skin cancer remain urgent problems. Histological examination of biopsy material-the gold standard of diagnosis-is an invasive procedure that requires a certain amount of time to perform. The ability to detect abnormal cells using fluorescence spectroscopy (FS) has been shown in many studies. Read More

View Article and Full-Text PDF
December 2021

Split-face comparative trial of 785-nm picosecond neodymium:yttrium-aluminum-garnet laser and precision cryotherapy combination treatment for facial benign pigmented lesions.

Dermatol Ther 2022 02 8;35(2):e15240. Epub 2021 Dec 8.

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea.

Cryotherapy (or cryosurgery) has been performed to treat various skin lesions in the field of dermatology; however, to the best of our knowledge, no study has investigated its efficacy and safety for benign pigmented lesions. Therefore, we conducted a split-face study to evaluate the efficacy and safety of cryotherapy in the treatment of benign pigmented lesions. A total of five subjects were included. Read More

View Article and Full-Text PDF
February 2022

In vivo two-photon-excited cellular fluorescence of melanin, NAD(P)H, and keratin enables an accurate differential diagnosis of seborrheic keratosis and pigmented cutaneous melanoma.

J Biomed Opt 2021 07;26(7)

University of Heidelberg, Department of Dermatology, Heidelberg, Germany.

Significance: Seborrheic keratoses (SKs) are harmless pigmented skin lesions (PSLs) that may be confused clinically not only with other benign conditions but also with cutaneous melanoma (CM). As SKs are one of the most common neoplasms in adults, the importance of their correct diagnosis is high. Misclassifying SK as malignant is not rare and leads to a high number of unnecessary biopsies. Read More

View Article and Full-Text PDF

Clinical Evaluation of Safety and Efficacy of a 670-nm Picosecond Laser for Treatment of Benign Pigmented Lesions in Asians.

Dermatol Surg 2021 05;47(5):e153-e158

All authors are affiliated with the Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. K.E.R. Evangelista is currently affiliated with the Department of Dermatology, Research Institute for Tropical Medicine, Manila, Philippines.

Background: Picosecond lasers are increasingly being investigated in treating pigmentation disorders because they may provide better treatment efficacy and comfort compared with nanosecond lasers.

Objective: This study aims to evaluate the efficacy and side effect of a novel 670-nm picosecond laser in the removal of benign pigmented lesions (BPLs) in individuals with Fitzpatrick skin types (FST) III and IV.

Materials And Methods: Fifteen subjects with solar lentigines and 7 subjects with ABNOMs received a single treatment with a 670-nm picosecond laser. Read More

View Article and Full-Text PDF

Asymptomatic disseminated telangiectasias: a rare case of cutaneous collagenous vasculopathy.

Dermatol Online J 2020 Oct 15;26(10). Epub 2020 Oct 15.

Department of Dermatology, Mater Hospital Brisbane, Queensland.

Cutaneous collagenous vasculopathy (CCV) is a rare idiopathic microangiopathy affecting superficial dermal blood vessels. It is characterized by asymptomatic, disseminated, telangiectatic macules that typically involve the extremities. We report the case of a 58-year-old woman who presented with widespread telangiectasias of three years' duration on the upper extremities and abdomen. Read More

View Article and Full-Text PDF
October 2020

[Treatment of nevus of Ota and Ito and epidermal nevus syndrome].

Hautarzt 2020 Dec;71(12):926-931

National Institute of Laser Enhanced Sciences (NILES), Cairo University, Giza, Ägypten.

Nevus of Ota, nevus of Ito and nevus of Hori are special melanocytic nevi that have a slate-brown or blue/grey coloring. They are pigmented disorders characterized by its heterotopic melanocytic dermal location and by blue/brown unilateral and sometimes bilateral facial patch in case of nevus of Ota, and in the supraclavicular, scapular, and deltoid region in case of nevus of Ito. It is more common in patients with Asian and dark-skinned ethnic backgrounds. Read More

View Article and Full-Text PDF
December 2020

Reflectance confocal microscopy evaluation of pigmented lesions on tattooed skin.

Lasers Med Sci 2021 Jul 17;36(5):1077-1084. Epub 2020 Oct 17.

Rao Dermatology, 95 First Avenue, Atlantic Highlands, NJ, 07716, USA.

The evaluation of pigmented lesions on tattooed skin poses a diagnostic challenge for dermatologists, as a nevus may be partially or completely obscured by tattoo pigment. Because of incidences of melanoma arising from tattooed skin, the current gold standard is to biopsy these lesions. Reflectance confocal microscopy (RCM) is a noninvasive imaging modality used in the diagnosis and management of skin diseases that may allow for diagnosis, while preserving the tattoo design. Read More

View Article and Full-Text PDF

Neurocutaneous melanocytosis (melanosis).

Childs Nerv Syst 2020 10 13;36(10):2571-2596. Epub 2020 Oct 13.

Pediatric Neurosurgery, International Neuroscience Institute (INI), Hannover, Germany.

Neurocutaneous melanosis (NCM; MIM # 249400; ORPHA: 2481], first reported by the Bohemian pathologist Rokitansky in 1861, and now more precisely defined as neurocutaneous melanocytosis, is a rare, congenital syndrome characterised by the association of (1) congenital melanocytic nevi (CMN) of the skin with overlying hypertrichosis, presenting as (a) large (LCMN) or giant and/or multiple (MCMN) melanocytic lesions (or both; sometimes associated with smaller "satellite" nevi) or (b) as proliferative melanocytic nodules; and (2) melanocytosis (with infiltration) of the brain parenchyma and/or leptomeninges. CMN of the skin and leptomeningeal/nervous system infiltration are usually benign, more rarely may progress to melanoma or non-malignant melanosis of the brain. Approximately 12% of individuals with LCMN will develop NCM: wide extension and/or dorsal axial distribution of LCMN increases the risk of NCM. Read More

View Article and Full-Text PDF
October 2020

Safety and Efficacy of a Novel 730 nm Picosecond Titanium Sapphire Laser for the Treatment of Benign Pigmented Lesions.

Lasers Surg Med 2021 04 1;53(4):429-434. Epub 2020 Sep 1.

Cosmetic Laser Dermatology, 9339 Genesee Avenue, Suite 300, San Diego, 92121, California.

Background And Objectives: Picosecond lasers in dermatology were originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have expanded its clinical indications to include treatment of benign pigmented lesions, photodamage, melasma, and scar revision. In this retrospective review, we evaluate a novel 730 nm picosecond titanium sapphire laser in treating benign pigmented lesions. Read More

View Article and Full-Text PDF

A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.

Lasers Surg Med 2021 01 31;53(1):95-103. Epub 2020 Aug 31.

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Background And Objectives: Treatment of melasma with lasers remains a challenge due to its limited clinical efficacy in addition to high rates of recurrence and side effects. Recently, picosecond lasers have shown favorable results in treatment of benign pigmented lesions. To compare the efficacy and safety of using a 755-nm picosecond laser for the treatment of melasma in a split-face manner, having one side treated with a fractionated beam (diffractive lens array [DLA] coupling) and with a full-beam (flat optics) on the other side. Read More

View Article and Full-Text PDF
January 2021

A New 675 nm Laser Device in the Treatment of Melasma: Results of a Prospective Observational Study.

Photobiomodul Photomed Laser Surg 2020 Sep 21;38(9):560-564. Epub 2020 Aug 21.

Unit of Dermatology, University of Rome, Tor Vergata, Rome, Italy.

This study evaluates the efficacy and safety of a new 675 nm laser source system on melasma. Melasma is an acquired circumscribed hyperpigmented disorder that has a negative impact on patients' life quality. Different treatments are currently available. Read More

View Article and Full-Text PDF
September 2020

A Unique Presentation of Gingival Melanoacanthoma: Case Report and Review of Literature.

Cureus 2020 Mar 18;12(3):e7315. Epub 2020 Mar 18.

Periodontics, Maulana Azad Institute of Dental Sciences, New Delhi, IND.

Melanoacanthoma is a benign, deeply pigmented condition of the oral mucosa characterized by the proliferation of melanocytes and keratinocytes. A 60-year-old male, with no history of systemic diseases or medical treatment, presented with an asymptomatic diffuse pigmentation involving the maxillary and mandibular gingiva. The histopathology of the anomalous pigmented area was analyzed and the dendritic melanocytes expressed positively for Masson-Fontana, S-100, and HMB-45. Read More

View Article and Full-Text PDF

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations.

Lasers Surg Med 2021 01 13;53(1):9-49. Epub 2020 Apr 13.

Wellman Center for Photomedicine, Massachusetts General Hospital, 50 Blossom Street, Boston, Massachusetts, 02114.

Background And Objectives: The use of picosecond laser in dermatology was originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have broadened its clinical indications to include treatment of benign pigmented lesions, photodamage, melasma, and scar revision. In this systematic review, evidence-based recommendations are developed for the use of picosecond laser in dermatology. Read More

View Article and Full-Text PDF
January 2021

Recent advances in managing and understanding seborrheic keratosis.

Authors:
Uwe Wollina

F1000Res 2019 28;8. Epub 2019 Aug 28.

Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, 01067, Germany.

Seborrheic keratosis (SK) is a common benign epidermal tumor with predominance in adult patients. Whereas common SKs are more frequent in Caucasians, dermatosis papulosa nigra is more prevalent in patients with a Fitzpatrick skin type of at least 3. There seems to be a link between extrinsic skin aging and the occurrence of SK. Read More

View Article and Full-Text PDF

Evolution of the Picosecond Laser: A Review of Literature.

Dermatol Surg 2019 02;45(2):183-194

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.

Background: Picosecond pulse duration lasers (PS) have altered the field of dermatology. PS were initially used in tattoo removal, to optimize efficacy and reduce side effects with nanosecond domain lasers. More recently, they have been demonstrated to be effective in the treatment of pigmentary disorders, acne scarring, and photoaging. Read More

View Article and Full-Text PDF
February 2019

Treatment of benign pigmented lesions using a novel Dermal Cooling System.

Lasers Surg Med 2019 01 27;51(1):59-61. Epub 2018 Nov 27.

Department of Dermatology, University of California San Diego, La Jolla 92122, California.

Benign pigmented lesions are among the most common dermatologic diagnoses that patients seek treatments for. Treatment modalities range from cryotherapy to light and laser-based technologies. These treatments have been shown to be effective, yet may lead to dyschromia or significant downtime. Read More

View Article and Full-Text PDF
January 2019

Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.

Lasers Surg Med 2019 01 25;51(1):14-22. Epub 2018 Oct 25.

Division of Dermatology, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Background And Objectives: Cutaneous pigmentary disorders are both more common and more difficult to treat in patients with skin color given the higher melanin content in the epidermis. Although Q-switched lasers are widely considered to be the standard treatment for both epidermal and dermal pigmentary conditions, a very high risk of post-inflammatory hyperpigmentation (PIH) of up to 25% is seen in patients with skin of color. Recently, the novel picosecond laser with pulse durations operating at sub-nanosecond domains has been shown to be effective in tattoo removal and in the treatment of acne scars. Read More

View Article and Full-Text PDF
January 2019

Long pulsed dye laser with a back-to-back double-pulse technique and compression for the treatment of epidermal pigmented lesions.

Lasers Surg Med 2019 02 15;51(2):136-140. Epub 2018 Oct 15.

Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 1600, Chicago 60611, Illinois.

Background: In the recent past, long pulsed dye lasers (LPDL) have been investigated for the treatment of epidermal pigmented lesions (EPLs). Using a pigmented lesion compression headpiece, blood is pushed laterally out of the laser field focusing laser energy on melanin. Recent studies have demonstrated excellent responses using a single-pulse at the following settings: 9-12 J/cm , 1. Read More

View Article and Full-Text PDF
February 2019

Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review.

J Dermatolog Treat 2019 Mar 18;30(2):105-109. Epub 2018 May 18.

a Department of Dermatology , University of Patras, University General Hospital of Patras , Rio , Greece.

Background: Pigmented purpuric dermatoses (PPDs) is a group of diseases with distinguishing clinical characteristics, characterized mainly by purpuric skin lesions. The course of PPDs is chronic and recurrences are common. Although PPDs are considered to be benign, the associated symptoms, such as pruritus, and their cosmetic effect can be extremely distressing to patients. Read More

View Article and Full-Text PDF

Picosecond Laser Treatment for Tattoos and Benign Cutaneous Pigmented Lesions (Secondary publication).

Authors:
Kenichiro Kasai

Laser Ther 2017 Dec;26(4):274-281

Kasai Clinic for Plastic Surgery.

Background And Aims: The selective removal of tattoos and benign cutaneous pigmented lesions with laser energy evolved rapidly with the development of the nanosecond-domain Q-switched laser (ns-laser). Recently, however, a series of picosecond-domain lasers (ps-lasers) with pulsewidths less than 1 ns has become commercially available, enabling more efficient and faster removal of pigmented lesions in the field of dermatologic laser surgery.

Rationale Behind The Ps-laser: The efficacy of the ns-laser depended on the theory of selective photothermolysis, whereby an extremely short pulse width was delivered less than the thermal relaxation time (TRT) of a target. Read More

View Article and Full-Text PDF
December 2017

Recurrence of melanocytic lesions after laser treatment: benign vs. malignant upon dermoscopy.

J Eur Acad Dermatol Venereol 2017 Dec 16;31(12):e526-e528. Epub 2017 Aug 16.

Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.

View Article and Full-Text PDF
December 2017

Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.

Lasers Surg Med 2017 11 29;49(9):819-826. Epub 2017 May 29.

Memorial Sloan Kettering Cancer Center, Dermatology Service, 16 E. 60th Street, 4th Floor Dermatology, New York, New York, 10022.

Introduction: Lentigo maligna (LM) is melanoma in situ on sun-damaged skin and presents diagnostic challenges due to overlapping features with benign pigmented lesions. Cosmetic treatments may be inadvertently performed on LM. The aim of this study is to estimate the prevalence of LM with prior cosmetic treatment, and evaluate surgical outcomes. Read More

View Article and Full-Text PDF
November 2017

Medium-sized nevus spilus of the neck treated with pulsed dye laser.

Dermatol Ther 2017 Jul 20;30(4). Epub 2017 Apr 20.

Abrusci Studio, Milan, Italy.

Patients with large benign melanocytic lesions located on the neck represent a therapeutic challenge since the neck is a high-risk area for hypertrophic scarring and/or retraction. When treating a benign, extensive and visible melanocytic lesion, the choice of therapy mainly depends on the likelihood of improved cosmesis. We report a case of a 33-year-old woman with a medium-sized Nevus Spilus located on the neck, successfully treated with four sessions of pulsed dye laser. Read More

View Article and Full-Text PDF

Argon Laser Photoablation for Treating Benign Pigmented Conjunctival Nevi.

Middle East Afr J Ophthalmol 2016 Jul-Sep;23(3):247-9

Department of Research, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Purpose: To evaluate the outcomes of argon laser photoablation of benign conjunctival pigmented nevi with different clinical presentations.

Patients And Methods: This interventional case series was conducted between July 2014 and January 2015. Patients presenting with benign conjunctival nevi were included. Read More

View Article and Full-Text PDF

Melanoma diagnosed in lesions previously treated by laser therapy.

J Dermatol 2017 Jan 27;44(1):23-28. Epub 2016 Jun 27.

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

Laser therapy has become a routine procedure in dermatological practice and is frequently also used for pigmented lesions. Few reports exist of melanomas diagnosed in lesions previously treated by laser therapy. Between 2007 and 2014, we identified 11 patients who presented to our department with a melanoma diagnosed in a region previously treated by laser therapy. Read More

View Article and Full-Text PDF
January 2017

Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians.

Lasers Surg Med 2016 Apr 12;48(4):354-9. Epub 2016 Jan 12.

Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Background/objective: Solar lentigines are benign pigmented lesions that occur mostly on sun-exposed areas. Q-switched and ablative lasers are effective for removing these lesions but the high incidence of postinflammatory hyperpigmentation raises concern in darker skin types. The objective of this study is to compare the efficacy and degree of postinflammatory hyperpigmentation with the Q-switched Nd:YAG and fractional carbon dioxide (CO2 ) laser for treatment of solar lentigines in Asians. Read More

View Article and Full-Text PDF